Association Between Triglycerides And Residual Cardiovascular Risk In Patients With Type 2 Diabetes Mellitus And Established Cardiovascular Disease (From The Bypass Angioplasty Revascularization Investigation 2 Diabetes [BARI 2D] Trial)

This research examined whether triglyceride levels - a type of fat in the blood - affect cardiovascular risk in people who already have two major health challenges: type 2 diabetes and established heart disease. The study followed 2,307 patients from the BARI 2D trial, tracking their health outcomes over time to understand how triglyceride levels influenced their risk of future heart problems.

The researchers found that about half of the patients had triglyceride levels below 150 mg/dL (considered normal), while the other half had elevated levels. Those with higher triglycerides tended to be younger but had worse overall metabolic health - they had higher BMI, lower HDL ("good") cholesterol, and poorer blood sugar control. They were also more likely to have previously experienced heart attacks or needed heart procedures.

The key finding was striking: for every 50 mg/dL increase in triglyceride levels, patients faced a nearly 4% higher risk of experiencing a heart attack, stroke, or cardiovascular death, and a 6.4% higher risk of dying from cardiovascular causes. This relationship held true even after accounting for other important factors like age, other cholesterol levels, and medication use.

For anyone focused on metabolic health and longevity, this study reinforces that triglycerides aren't just a number on a lab report - they're an independent risk factor that deserves attention. In clinical practice, this research supports aggressive triglyceride management through lifestyle modifications and medications when appropriate, especially for high-risk patients with diabetes and heart disease, as part of a comprehensive approach to reducing cardiovascular risk.